#ASCO20 | #JAVELINBladder100 trial: treatment with #avelumab combined with best supportive care following CT significantly extended OS compared with best supportive care alone in patients with advanced urothelial cancer.

#ASCO20 Plenary ongoing LBA1: Most significant survival benefit seen with any immunotherapy in advanced UC #bladdercancer to date. First line maintenance Rx with avelumab improved OS . New standard of care. Tom Powles Petros Grivas ASCO

New article: Isatuximab plus Pomalidomide and Dexamethasone in a Patient with Dialysis-Dependent Multiple Myeloma link.paperbirds.me/SBWrWp #MMSM #MultipleMyeloma #hematology

New article: Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial link.paperbirds.me/SBvGKV #MMSM #MultipleMyeloma #hematology

How I treat myeloma. Updated #ASH21 edition algorithms. #ASH21VR @MayoMyeloma I modified the first relapse algorithm to indicate that isatuximab can be used instead of daratumumab in certain regimens. ASH

Isatuximab Plus RVd Improves MRD Negativity Rates in Transplant-Eligible, Newly Diagnosed Myeloma More medical news at medpub.io #Oncology #MedTwitter #MedEd #MedNews onclive.com/view/isatuxima…

Isatuximab Plus RVd Improves MRD Negativity Rates in Transplant-Eligible, Newly Diagnosed Myeloma For more up-to-date medical headlines, visit medpub.io #MedicalNews #MedTwitter #MedEd #MedNews onclive.com/view/isatuxima…

#ASH21 Hartmut Goldschmidt—Addition of isatuximab to lenalidomide, bortezomib and dexamethasone improves MRD negativity at the end of induction for patients with newly-diagnosed, transplant-eligible multiple myeloma: results from the phase 3 GMMG-HD7 trial #mmsm

GMMG HD-7 trial of over 650 patients treated with VRD +/- Isatuximab in frontline MM for 6 cycles. Impressive to choose MRD as primary endpoint. Again quad approach superior to triplet. #ash21 #myelomawithmikhael

From ASH 2021 RT The Lancet Haematology: #ASH21 Hartmut Goldschmidt—Addition of isatuximab to lenalidomide, bortezomib and dexamethasone improves MRD negati… x.com/i/web/status/1…

#ASH21 | Hartmut Goldschmidt Universitätsklinikum Heidelberg presents the GMMG-HD7 trial, powered to evaluate MRD neg after induction with isatuximab + VRd vs VRd in ND #myeloma. Response rate was similar regardless cytogenetic risk, but MRD data still needs to be analyzed #mmsm

Addition of Isatuximab to VRD As Induction Therapy for TE NDMM: The Phase III GMMG-HD7 Trial - 662 randomized with MRD negative by NGF 50% in Isa-RVd arm and 35.6% in RVd arm. No significant effect on safety. - Hartmut Goldschmidt #ASH21 #mmsm #ASH21_MSKMM

#Sanofi reported that #Sarclisa (#Isatuximab) trial is first Phase 3 study to meet primary endpoint of minimal residual disease negativity in transplant-eligible patients with newly diagnosed #MultipleMyeloma 1stoncology.com/blog/sarclisa-…

Proud to be the 73rd 😎 on BackerKit for Lodge Solar Powered Speakers. …-solar-powered-speakers.backerkit.com/community_shar…

👏 CONCEPT Trial: High, sustainable MRD-negativity rates with Isatuximab, Carfilzomib, Lenalidomide, & Dexamethasone in newly diagnosed high-Risk #MultipleMyeloma ➡️ brnw.ch/21wEe56 #mmsm

JUSTIN Vineyards & Winery have tried several times to get someone to call us back about a wedding. Our favorite winery that we would love to get married at, but no one will return our calls.

Adam Levine - Don't Let Me Down live on the howard stern show (The Beatl... youtu.be/uV1aib21n-8 via YouTube Adam Levine - going to make this our first dance song at our wedding. Love your version!